Canakinumab Subcutaneous and Oxymetazoline Topical application
Determining the interaction of Canakinumab Subcutaneous and Oxymetazoline Topical application and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: oxymetazoline topical
Brand name: Rhofade
Synonyms: Oxymetazoline topical, Oxymetazoline (Topical)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Oxymetholone
- Canakinumab Subcutaneous-Oxymorphone
- Canakinumab Subcutaneous-Oxymorphone Extended-Release Tablets
- Canakinumab Subcutaneous-Oxymorphone Hydrochloride
- Canakinumab Subcutaneous-Oxymorphone Injection
- Canakinumab Subcutaneous-Oxymorphone Tablets
- Oxymetazoline Topical application-Canasa
- Oxymetazoline Topical application-Canasa Pac rectal
- Oxymetazoline Topical application-Canasa rectal
- Oxymetazoline Topical application-Cancidas
- Oxymetazoline Topical application-Candesartan
- Oxymetazoline Topical application-Candesartan and Hydrochlorothiazide